Raloxifene Hydrochloride

• CAT Number: A001074
• CAS Number: 82640-04-8
• Molecular Formula: C28H27NO4S ? HCl
• Molecular Weight: 510.21
• Purity: ≥95%
• Synonyms: LY156758 (Keoxifene) HCl; LY156758 hydrochloride
• Target: Autophagy
• Solubility: 10 mM in DMSO
• Storage: 3 years -20°C powder
• IUPAC Name: [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride
• InChI: InChI=1S/C28H27NO4S.ClH/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29;/h4-13,18,30-31H,1-3,14-17H2;1H
• InChIKey: BKXVVCILCIUCLG-UHFFFAOYSA-N
• SMILES: OC1=CC=C(C(C(C2=CC=C(OCCN3CCCCC3)C=C2)=O)=C(C4=CC=C(O)C=C4)S5)C5=C1.Cl

Raloxifene Hydrochloride(CAT: A001074) is a selective estrogen receptor modulator (SERM) that exhibits tissue-specific estrogenic and anti-estrogenic effects. It acts as an estrogen agonist in bone, promoting bone density, and as an antagonist in breast and uterine tissues, reducing the risk of hormone-dependent cancers. This compound is particularly valuable in endocrinology and oncology research, supporting studies on osteoporosis, breast cancer prevention, and hormone signaling. Raloxifene Hydrochloride is a crucial tool for exploring the therapeutic potential of SERMs in bone health and estrogen-related disorders, contributing to advancements in drug discovery and personalized medicine.